What is the main business of Piotr Dziemidok Badania Kliniczne?

The main business activity of Piotr Dziemidok Badania Kliniczne focuses on other research and experimental development on natural sciences and engineering.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on January 29, 2021.

Where is the headquarters located?

The headquarters is located at: ul. Księdza Jerzego Popiełuszki 28G, 20-052 Lublin.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

In 2025, the company generated total revenue of $14,269, representing an increase of 38174.0% compared to 2024.

Yes, in 2025 the company was profitable, achieving a net profit of $12,197.

Piotr Dziemidok Badania Klinicznesp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2021-01-29

Share capital

5,000.00 PLN

Registered address

ul. Księdza Jerzego Popiełuszki 28G/3, 20-052 Lublin, Poland

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)

$1,208

Filing timeliness

1 of 5 financial statements was filed late (for 2021, 90 days late).

202518/06/2026
202403/07/2025
202309/07/2024
202206/07/2023
202113/10/2022

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 14.27kMedianUSD 73.26kAverageUSD 3.23m

Net profit

This companyUSD 12.20kMedianUSD 68.58AverageUSD 82.17k

Operating costs

This companyUSD 769.85MedianUSD 75.78kAverageUSD 3.04m

Assets

This companyUSD 13.39kMedianUSD 119.88kAverageUSD 3.90m

Industry

Other research and experimental development on natural sciences and engineering (72.19.Z)Primary

Authorized Representatives

Piotr Dziemidok – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Piotr Dziemidokage 64	30	$810.37	60%
Agnieszka Siemionow Dziemidokage 58	20	$540.25	40%

Piotr Dziemidok and Agnieszka Siemionow Dziemidok hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Ekamedsp. z o.o.	$1,386,944.70	ekamed.pl
Albi-Techsp. z o.o.	$288,607.46	albi-tech.pl
Sfpesp. z o.o.	$253,801.53	sfpe.co.pl
OPESsp. z o.o.	$100,989.20	opes.com.pl
Findewalsp. z o.o.	$96,002.27	findewal.pl
Water In Saltsp. z o.o.	$1,453.27	waterinsalt.com
L-Conesp. z o.o.	$803.90	l-cone.pl
Heiki Heikisp. z o.o.	$113.96	heikiheiki.com
Wheelstairsp. z o.o.	$6.93	wheelstair.com
Aeronite Technologiessp. z o.o.	$0.00	aeronite.com